Concepedia
Statistics
Publications
11
Citations
896
H-Index
10
Active since
2011
Affiliations
Synta Pharmaceuticals (United States)(Current)
Cairn University
VA Boston Healthcare System
Fox Chase Cancer Center
Luisa Shin Ogawa is an author at Synta Pharmaceuticals (United States) specializing in pharmacology, medicine, and oncology.
Publications per year
2011–2018
The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
Masazumi Nagai, Nha Huu Vo, Luisa Shin Ogawa et al. · Free Radical Biology and Medicine · 2012 · 354 citations
Life Sciences, Oncology, Pharmacology +15
Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations
Medicine, Oncology, Pharmacology +11
FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism
Jaime Acquaviva, Suqin He, Chaohua Zhang et al. · Molecular Cancer Research · 2014 · 76 citations
Medicine, Oncology, Pharmacology +16
A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors
Dan Zhou, Yuan Liu, Josephine Ye et al. · Toxicology and Applied Pharmacology · 2013 · 74 citations · Full text
Medicine, Ophthalmology, Pharmacology +16
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib
Hannes Landmann, David A. Proia, Sen He et al. · Cell Death and Disease · 2014 · 42 citations · Full text
Medicine, Oncology, Pharmacology +10
1–5 of 11